Cost-effectiveness of stroke unit care followed by early supported discharge O Saka, V Serra, Y Samyshkin, A McGuire, CCDA Wolfe Stroke 40 (1), 24-29, 2009 | 158 | 2009 |
Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial … M Baxter, R Hudson, J Mahon, C Bartlett, Y Samyshkin, D Alexiou, N Hex Diabetic Medicine 33 (11), 1575-1581, 2016 | 137 | 2016 |
A framework and toolkit for capturing the communicable disease programmes within health systems: tuberculosis control as an illustrative example RA Atun, N Lennox-Chhugani, F Drobniewski, YA Samyshkin, RJ Coker The European Journal of Public Health 14 (3), 267-273, 2004 | 111 | 2004 |
Barriers to sustainable tuberculosis control in the Russian Federation health system RA Atun, YA Samyshkin, F Drobniewski, NM Skuratova, G Gusarova, ... Bulletin of the World Health Organization 83 (3), 217-223c, 2005 | 87 | 2005 |
Tuberculosis control in Samara Oblast, Russia: institutional and regulatory environment RJ Coker, B Dimitrova, F Drobniewski, Y Samyshkin, Y Balabanova, ... The International Journal of Tuberculosis and Lung Disease 7 (10), 920-932, 2003 | 72 | 2003 |
Seasonal variation and hospital utilization for tuberculosis in Russia: hospitals as social care institutions RA Atun, YA Samyshkin, F Drobniewski, SI Kuznetsov, IM Fedorin, ... The European Journal of Public Health 15 (4), 350-354, 2005 | 69 | 2005 |
Mental health reform in the Russian Federation: an integrated approach to achieve social inclusion and recovery R Jenkins, S Lancashire, D McDaid, Y Samyshkin, S Green, J Watkins, ... Bulletin of the World health Organization 85 (11), 858-866, 2007 | 68 | 2007 |
Cost-effectiveness of available treatment options for patients suffering from severe COPD in the UK: a fully incremental analysis N Hertel, RW Kotchie, Y Samyshkin, M Radford, S Humphreys, ... International journal of chronic obstructive pulmonary disease, 183-199, 2012 | 67 | 2012 |
Health-systems efficiency in the Russian Federation: tuberculosis control K Floyd, R Hutubessy, Y Samyshkin, A Korobitsyn, I Fedorin, ... Bulletin of the World Health Organization 84 (1), 43-51, 2006 | 58 | 2006 |
Cost-effectiveness models for chronic obstructive pulmonary disease: cross-model comparison of hypothetical treatment scenarios M Hoogendoorn, TL Feenstra, Y Asukai, S Borg, RN Hansen, SA Jansson, ... Value in health 17 (5), 525-536, 2014 | 51 | 2014 |
Utilising artificial intelligence to determine patients at risk of a rare disease: idiopathic pulmonary arterial hypertension DG Kiely, O Doyle, E Drage, H Jenner, V Salvatelli, FA Daniels, J Rigg, ... Pulmonary circulation 9 (4), 2045894019890549, 2019 | 44 | 2019 |
Long-term cost-utility analysis of exenatide once weekly versus insulin glargine for the treatment of type 2 diabetes patients in the US Y Samyshkin, AL Guillermin, JH Best, SC Brunell, A Lloyd Journal of medical economics 15 (sup2), 6-13, 2012 | 44 | 2012 |
Health system factors impacting on delivery of mental health services in Russia: multi-methods study D McDaid, YA Samyshkin, R Jenkins, A Potasheva, A Nikiforov, RA Atun Health Policy 79 (2-3), 144-152, 2006 | 43 | 2006 |
Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes … WC Lee, Y Samyshkin, J Langer, JL Palmer Journal of medical economics 15 (sup2), 28-37, 2012 | 41 | 2012 |
Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom Y Samyshkin, RW Kotchie, AC Mörk, AH Briggs, ED Bateman The European Journal of Health Economics 15, 69-82, 2014 | 39 | 2014 |
Costs and outcomes of tuberculosis control in the Russian Federation: retrospective cohort analysis RA Atun, Y Samyshkin, F Drobniewski, Y Balabanova, IM Fedorin, J Lord, ... Health Policy and Planning 21 (5), 353-364, 2006 | 34 | 2006 |
Long-term cost-consequence analysis of exenatide once weekly vs sitagliptin or pioglitazone for the treatment of type 2 diabetes patients in the United States AL Guillermin, A Lloyd, JH Best, MB DeYoung, Y Samyshkin, JA Gaebler Journal of medical economics 15 (4), 654-663, 2012 | 33 | 2012 |
Cost-effectiveness of roflumilast in combination with bronchodilator therapies in patients with severe and very severe COPD in Switzerland Y Samyshkin, M Schlunegger, S Haefliger, S Ledderhose, M Radford International Journal of Chronic Obstructive Pulmonary Disease, 79-87, 2013 | 30 | 2013 |
Social factors influencing hospital utilisation by tuberculosis patients in the Russian Federation: analysis of routinely collected data RA Atun, YA Samyshkin, F Drobniewski, SI Kuznetsov, IM Fedorin, ... The International Journal of Tuberculosis and Lung Disease 9 (10), 1140-1146, 2005 | 30 | 2005 |
Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis AL Guillermin, Y Samyshkin, D Wright, T Nguyen, J Villeneuve Journal of Medical Economics 14 (2), 207-216, 2011 | 29 | 2011 |